| Title |
Author |
Type |
Date |
Words |
| Aurion Biotech trial shows IOTA cell therapy can restore vision to patients with blindness resulting from corneal endothelial disease. |
|
|
Jul 26, 2021 |
286 |
| AbbVie's DALVANCE receives US FDA approval. |
|
|
Jul 26, 2021 |
160 |
| AbbVie's DALVANCE receives US FDA approval. |
|
|
Jul 26, 2021 |
161 |
| Acticor Biotech Completes Enrollment in its GARDEN Clinical Trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study. |
|
Clinical report |
Jul 23, 2021 |
449 |
| Abeona activates second clinical trial site for EB-101 Phase 3 VITAL study. |
|
|
Jul 23, 2021 |
188 |
| Landos Biopharma to present Phase 3 data of omilancor in UC at UEGW. |
|
|
Jul 22, 2021 |
280 |
| Biogen says FDA approval of ADUHELM based on thorough analysis of data. |
|
|
Jul 22, 2021 |
705 |
| Adagene announces clinical trial collaboration with Merck. |
|
|
Jul 22, 2021 |
258 |
| eFFECTOR Therapeutics doses first patient in Phase 1b trial of zotatifin. |
|
|
Jul 22, 2021 |
304 |
| Antares Pharma announces FDA acceptance of IND application for ATRS-1902. |
|
|
Jul 22, 2021 |
262 |
| RenovaCare provides update on clinical trial for SkinGun, CellMist System. |
|
|
Jul 22, 2021 |
178 |
| Eureka Therapeutics Initiates Phase I/II ARYA-3 Clinical Trial of GPC3 Targeting ARTEMIS T Cell Therapy in Liver Cancer. |
|
|
Jul 22, 2021 |
422 |
| Antengene's ATG-101 clinical trial application receives Australian regulatory approval. |
|
|
Jul 22, 2021 |
157 |
| Antengene's ATG-101 clinical trial application receives Australian regulatory approval. |
|
|
Jul 22, 2021 |
156 |
| Free Event Explores Real Clinical Trial Experiences. |
CISCRP |
|
Jul 22, 2021 |
230 |
| First Patient Enrolled in Clinical Trial for Vicineum in China. |
|
|
Jul 21, 2021 |
746 |
| Merck Presents New Data from Ongoing Phase 2a Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of Investigational, Once-Monthly, Oral Islatravir for HIV-1 Prevention. |
|
|
Jul 21, 2021 |
664 |
| Direct awarded US FDA approval to commence a Phase I/II trial of ExoFlo for post-acute COVID-19 syndrome. |
|
|
Jul 21, 2021 |
261 |
| Direct awarded US FDA approval to commence a Phase I/II trial of ExoFlo for post-acute COVID-19 syndrome. |
|
|
Jul 21, 2021 |
260 |
| Boston Scientific reports 'positive' results from PINNACLE FLX clinical trial. |
|
Clinical report |
Jul 21, 2021 |
278 |
| Oramed's Oravax oral vaccine clinical trial approved by Israel's IRB. |
|
|
Jul 21, 2021 |
244 |
| Sorrento Therapeutics doses COVID-19 patients in Phase 2 trial for COVIDROPS. |
|
|
Jul 21, 2021 |
310 |
| Acadia Pharmaceuticals phase 3 trial of pimavanserin met primary endpoint. |
|
Clinical report |
Jul 21, 2021 |
218 |
| Taiwan CECC mulls trials on mixing domestic COVID vaccine with others. |
|
|
Jul 21, 2021 |
195 |
| MediWound says primary endpoints met in Phase 3 pediatric study of NexoBrid. |
|
Clinical report |
Jul 20, 2021 |
788 |
| Rain Therapeutics initiates Phase 3 MANTRA clinical trial of milademetan. |
|
|
Jul 20, 2021 |
252 |
| Wave Life Sciences initiates dosing in Phase 1b/2a FOCUS-C9 trial of WVE-004. |
|
|
Jul 20, 2021 |
285 |
| Sesen Bio, Qilu announce enrollment of first patient in Vicineum trial in China. |
|
|
Jul 20, 2021 |
170 |
| 1,000 second doses of Nano Covax COVID-19 vaccine administered to volunteers in third-phase trials. |
|
|
Jul 20, 2021 |
275 |
| BlueRock Therapeutics DA01 receives Fast Track designation for advanced Parkinson's disease. |
|
|
Jul 20, 2021 |
177 |
| BlueRock Therapeutics DA01 receives Fast Track designation for advanced Parkinson's disease. |
|
|
Jul 20, 2021 |
176 |
| Merck says islatravir 'well tolerated versus placebo' in Phase 2a trial. |
|
|
Jul 20, 2021 |
155 |
| Kadmon says ROCKstar clinical trial of REZUROCK to treat cGVHD published. |
|
|
Jul 19, 2021 |
154 |
| Prometheus announces initiation of phase 2 clinical trial of PRA023. |
|
Clinical report |
Jul 19, 2021 |
163 |
| Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain. |
|
|
Jul 19, 2021 |
482 |
| NAFDAC Insists On Clinical Trial For COVID-19 Herbal Medicine. |
|
|
Jul 18, 2021 |
893 |
| Synlogic commences phase one SYNB1934 clinical trial to treat Phenylketonuria. |
|
|
Jul 16, 2021 |
231 |
| Synlogic commences phase one SYNB1934 clinical trial to treat Phenylketonuria. |
|
|
Jul 16, 2021 |
230 |
| Zendal, IAVI Partner to Advance the Tuberculosis Vaccine Candidate MTBVAC into Efficacy Trials. |
|
|
Jul 16, 2021 |
675 |
| Castor Raises USD 45m Series B to Modernize the Clinical Trial Process. |
|
|
Jul 16, 2021 |
406 |
| AstraZeneca-jabbed up to 3 times more likely to get Covid than Pfizer, study claims; Scientists at Imperial College London have used estimates from clinical trial data, including Public Health England, to suggest the AstraZeneca jab preventing symptoms of Covid less than Pfizer. |
By, Ryan Merrifield |
|
Jul 16, 2021 |
591 |
| Medable sets up new EMEA HQ in Dublin to support clinical trial deployments in Europe. |
|
|
Jul 15, 2021 |
223 |
| Medable sets up new EMEA HQ in Dublin to support clinical trial deployments in Europe. |
|
|
Jul 15, 2021 |
222 |
| Medable sets up new EMEA HQ in Dublin to support clinical trial deployments in Europe. |
|
|
Jul 15, 2021 |
225 |
| Transcenta Holding doses first US patient in global TST005 phase one clinical trial. |
|
|
Jul 15, 2021 |
166 |
| Transcenta Holding doses first US patient in global TST005 phase one clinical trial. |
|
|
Jul 15, 2021 |
167 |
| 13,000 shots of Nano Covax vaccine administered to volunteers in third trial phase. |
|
|
Jul 15, 2021 |
237 |
| Theratechnologies initiates search for partner for Phase 3 tesamorelin trial. |
|
|
Jul 15, 2021 |
341 |
| FDA accepts NLS Pharmaceutics' Quilience IND application to treat narcolepsy. |
|
|
Jul 15, 2021 |
193 |
| Vir Biotechnology initiates Phase 2 clinical trial evaluating VIR-2218, VIR-3434. |
|
|
Jul 15, 2021 |
178 |
| Eli Lilly, Banner Alzheimer's Institue collaborate on Phase 3 trial of donanemab. |
|
Clinical report |
Jul 15, 2021 |
190 |
| Merck reports 'positive' event-free survival data from Phase 3 KEYNOTE-522 study. |
|
|
Jul 15, 2021 |
337 |
| ImmunityBio Authorized to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-Cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19. |
|
|
Jul 15, 2021 |
759 |
| AVM Biotechnology receives FDA approval to alter ongoing clinical study. |
|
|
Jul 14, 2021 |
194 |
| Kintor Pharmaceutical's GT20029 Investigational New Drug application receives US FDA approval. |
|
|
Jul 14, 2021 |
164 |
| Micron begins first microneedle vaccine clinical trial for measles and rubella at the London School of Hygiene and Tropical Medicine in The Gambia. |
|
|
Jul 14, 2021 |
265 |
| Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. |
|
|
Jul 14, 2021 |
156 |
| AVM Biotechnology receives FDA approval to alter ongoing clinical study. |
|
|
Jul 14, 2021 |
195 |
| Kintor Pharmaceutical's GT20029 Investigational New Drug application receives US FDA approval. |
|
|
Jul 14, 2021 |
165 |
| First Patient Dosed in Phase 1 Clinical Trial Evaluating CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. |
|
|
Jul 14, 2021 |
607 |
| FDA Approves Accelerated Dosing in Non-Hodgkin's Lymphoma/Leukemia Clinical Trial. |
|
|
Jul 14, 2021 |
417 |
| Micron begins first microneedle vaccine clinical trial for measles and rubella at the London School of Hygiene and Tropical Medicine in The Gambia. |
|
|
Jul 14, 2021 |
264 |
| Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. |
|
|
Jul 14, 2021 |
155 |
| Tevogen Bio wins FDA clearance of IND Application for TVGN-489 for COVID-19. |
|
|
Jul 13, 2021 |
232 |
| Tevogen Bio wins FDA clearance of IND Application for TVGN-489 for COVID-19. |
|
|
Jul 13, 2021 |
231 |
| Merck Presents Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19. |
|
|
Jul 13, 2021 |
351 |
| Lava Therapeutics announces treatment of first patient in Phase 1/2a of LAVA-051. |
|
|
Jul 13, 2021 |
306 |
| Genocea doses first patient in Phase 1/2a TiTAN clinical trial for GEN-011. |
|
|
Jul 13, 2021 |
166 |
| Galecto resumes recruitment in Phase 2b global GALACTIC-1 trial of GB0139. |
|
|
Jul 13, 2021 |
184 |
| TFF Pharmaceuticals announces preliminary data from Phase 1 clinical trial. |
|
|
Jul 13, 2021 |
291 |
| Hepion announces all primary endpoints achieved in Phase 2a AMBITION trial. |
|
|
Jul 13, 2021 |
313 |
| ARCA Biopharma provides update on ASPEN-COVID-19 Phase 2b clinical trial. |
|
|
Jul 13, 2021 |
269 |
| Moleculin Biotech receives approval for amendment in Annamycin trial. |
|
|
Jul 13, 2021 |
176 |
| Aptorum Group Touts Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus. |
|
|
Jul 13, 2021 |
359 |
| Solidarity trial also seeks to identify Covid-19 vaccine suited for Filipinos. |
|
|
Jul 13, 2021 |
255 |
| Pakistan earned $10mn from CanSino phase 3 trials: NIH. |
|
|
Jul 12, 2021 |
284 |
| Kintor receives USFDA approval for pyrilutamide phase two clinical trial. |
|
|
Jul 12, 2021 |
227 |
| ReiThera announces safe preliminary Phase 2 data from its GRAd-COV2 vaccine candidate. |
|
|
Jul 12, 2021 |
252 |
| Kintor receives USFDA approval for pyrilutamide phase two clinical trial. |
|
|
Jul 12, 2021 |
226 |
| Lysogene Receives FDA Fast Track Designation for LYS-GM101 Gene Therapy for the Treatment of GM1 Gangliosidosis. |
|
|
Jul 12, 2021 |
415 |
| ReiThera announces safe preliminary Phase 2 data from its GRAd-COV2 vaccine candidate. |
|
|
Jul 12, 2021 |
251 |
| Inotrem Receives Approval to Expand Nangibotide Clinical Trial in Critically Ill COVID-19 Patients and Receives Additional Public Funding of EUR 45m. |
|
|
Jul 12, 2021 |
801 |
| Merck, Ridgeback report interim data from Phase 2/3 studies of molnupiravir. |
|
|
Jul 12, 2021 |
215 |
| Arcutis announces first patient enrolled in phase 3 trial of ARQ-154. |
|
|
Jul 12, 2021 |
175 |
| Summit Therapeutics presents data from Phase II studies on ridinilazole. |
|
|
Jul 12, 2021 |
264 |
| Equillium to begin Phase 3 of itolizumab to treat severe autoimmune diseases. |
|
|
Jul 12, 2021 |
315 |
| Prilenia's Phase 3 Huntington's Disease Clinical Trial Achieves 50% Enrollment. |
|
|
Jul 12, 2021 |
291 |
| FDA Approves of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme. |
|
|
Jul 12, 2021 |
393 |
| Morphic reports data from Phase 1 study of MORF-057. |
|
|
Jul 9, 2021 |
508 |
| AIM ImmunoTech announces Phase 2a Human Challegene Trial of Ampligen. |
|
|
Jul 9, 2021 |
270 |
| Galectin Therapeutics announces results from Phase 1b trial extension. |
|
|
Jul 9, 2021 |
374 |
| Akston Biosciences Touts Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate. |
|
|
Jul 9, 2021 |
421 |
| Celldex presents 'positive' data from CDX-0159 phase 1b study. |
|
|
Jul 9, 2021 |
274 |
| SZAMBU completes volunteer recruitment for Covid-19 vaccine trial. |
|
|
Jul 8, 2021 |
424 |
| Can-Fite done preparing for start of patient enrollment in Namodenoson study. |
|
|
Jul 8, 2021 |
202 |
| Lysogene reports FDA fast track designation for LYS-GM101 gene therapy. |
|
|
Jul 8, 2021 |
201 |
| PureTech Inks Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors. |
|
|
Jul 8, 2021 |
641 |
| We need Shs2b for Covidex clinical trials, says Ogwang. |
|
|
Jul 8, 2021 |
1824 |
| Sanofi and GSK get approval for late-stage trial of COVID-19 vaccine candidate in India. |
|
|
Jul 8, 2021 |
194 |
| Sanofi and GSK get approval for late-stage trial of COVID-19 vaccine candidate in India. |
|
|
Jul 8, 2021 |
195 |
| Alvotech Initiates Clinical Studies for AVT04, A Proposed Biosimilar to Stelara (Ustekinumab). |
|
|
Jul 8, 2021 |
948 |
| Oxford scientists begin trial on novel HIV vaccine. |
|
|
Jul 7, 2021 |
238 |
| Trials for cattle TB vaccine begin; NEWS IN BRIEF. |
|
|
Jul 7, 2021 |
162 |
| Oxford scientists begin trial on novel HIV vaccine. |
|
|
Jul 7, 2021 |
238 |
| Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. |
|
|
Jul 7, 2021 |
258 |
| Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. |
|
|
Jul 7, 2021 |
257 |
| Iveric Bio Receives FDA Agreement Under Special Protocol Assessment for GATHER2 Phase 3 Clinical Trial of Zimura in Geographic Atrophy Secondary to Age-Related Macular Degeneration. |
|
|
Jul 7, 2021 |
783 |
| PureTech in clinical trial supply pact with BeiGene to evaluate tislelizumab. |
|
|
Jul 7, 2021 |
299 |
| Abeona Therapeutics updates EB-101 Phase 1/2a results in RDEB. |
|
|
Jul 7, 2021 |
197 |
| Atossa receives regulatory approval to open study of AT-H201 in Australia. |
|
|
Jul 7, 2021 |
277 |
| Fresh hope to end badger cull as bTB skin test trials for cows get underway; The move, coupled with the pilot of a vaccine, could spell the end for the badger killing programme within four years. |
By, Ben Glaze |
|
Jul 7, 2021 |
767 |
| Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. |
|
|
Jul 6, 2021 |
270 |
| China Regulator Accepts Antengene IND Application for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of Myelofibrosis. |
|
|
Jul 6, 2021 |
762 |
| Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. |
|
|
Jul 6, 2021 |
271 |
| Iveric bio receives FDA agreement under SPA for GATHER2 Phase 3 trial. |
|
|
Jul 6, 2021 |
424 |
| CytoSorbents receives full FDA approval of IDE for U.S. STAR-T trial. |
|
|
Jul 6, 2021 |
251 |
| Arrowhead announces interim clinical data from AROHIF21001 cohorts. |
|
Clinical report |
Jul 6, 2021 |
354 |
| Adial Pharmaceuticals says Phase 3 ONWARD trial nears enrollment completion. |
|
|
Jul 6, 2021 |
264 |
| FDA clears Sorrento Phase 2 trial of resiniferatoxin for OA knee pain. |
|
|
Jul 6, 2021 |
199 |
| Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara. |
|
|
Jul 6, 2021 |
337 |
| Phase 2 Glioblastoma Trial Shows Improved Progression-Free Survival. |
|
|
Jul 5, 2021 |
343 |
| Two FDA-Sanctioned Clinical Trials In Parkinson's. |
|
|
Jul 5, 2021 |
210 |
| Globe Biotech workers assaulted while catching monkeys for vaccine trial. |
|
|
Jul 4, 2021 |
296 |
| Final stage of human trials for homegrown Nano Covax vaccine begins. |
|
|
Jul 2, 2021 |
235 |
| Eric 'rings the bell' after poster helped him see off cancer; ex-builder opted for trial treatment. |
ELLEN KIRWIN ECHO Reporter ellen.kirwin@trinitymirror.com @ellen_kirwin |
|
Jul 2, 2021 |
495 |
| DOST waiting for WHO protocol on vaccine trials. |
|
|
Jul 1, 2021 |
424 |
| HDT Bio Receives Notice to Proceed from FDA for US Phase 1 Clinical Trial of RNA COVID-19 Vaccine. |
|
|
Jul 1, 2021 |
430 |
| Ault Global Holdings portfolio company Alzamend submits AL001 IND in Alzheimer's. |
|
|
Jul 1, 2021 |
278 |
| Kintara Therapeutics announces topline Phase 2 data results of VAL-083 in GBM. |
|
Financial report |
Jul 1, 2021 |
178 |
| Achilles Therapeutics enroll first patient in ongoing Phase I/IIa study in NSCLC. |
|
|
Jul 1, 2021 |
279 |
| Alzamend Neuro Submits IND Application for AL001 for Dementia Related to Alzheimer's Disease. |
|
|
Jul 1, 2021 |
515 |
| Precision BioSciences Doses First Patient in Phase 1 Allogeneic CAR T Clinical Trial of PBCAR19B Immune Evading Stealth Cell for Relapsed/Refractory Non-Hodgkin Lymphoma. |
|
|
Jul 1, 2021 |
542 |
| AM-Pharma Enrolls First Patient in Japan for Ongoing Phase III SA-AKI Pivotal REVIVAL Trial. |
|
|
Jul 1, 2021 |
460 |
| Novavax publishes results of UK Phase 3 trial of Covid-19 vaccine in NEJM. |
|
|
Jun 30, 2021 |
210 |
| Ocuphire Pharma says VEGA-1 Phase 2 trial meets primary, secondary endpoints. |
|
|
Jun 30, 2021 |
246 |
| Allogene Therapeutics granted Fast Track designation for ALLO-605. |
|
|
Jun 30, 2021 |
221 |
| Sellas Life Sciences reports data from ongoing Phase 1/2 study of GPS. |
|
|
Jun 30, 2021 |
568 |
| Savara announces first patient dosed in Phase 3 aPAP trial. |
|
|
Jun 30, 2021 |
189 |
| Cuba commences vaccine trials on children with its domestic COVID-19 vaccine. |
|
|
Jun 30, 2021 |
198 |
| Cuba commences vaccine trials on children with its domestic COVID-19 vaccine. |
|
|
Jun 30, 2021 |
197 |
| Direct Biologics wins FDA approval for Phase I/II trial for ExoFlo to treat mild-to-moderate COVID-19. |
|
|
Jun 30, 2021 |
201 |
| Direct Biologics receives US FDA approval for ExoFlo Phase I/II trial. |
|
|
Jun 30, 2021 |
178 |
| Direct Biologics wins FDA approval for Phase I/II trial for ExoFlo to treat mild-to-moderate COVID-19. |
|
|
Jun 30, 2021 |
202 |
| Direct Biologics receives US FDA approval for ExoFlo Phase I/II trial. |
|
|
Jun 30, 2021 |
179 |
| First Patient Dosed in Phase 1 Study of VNRX-9945 for the Treatment of Chronic Hepatitis B Virus Infection. |
|
|
Jun 30, 2021 |
348 |
| First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis Trial. |
|
|
Jun 30, 2021 |
393 |
| Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-ANG3 for Treatment of Mixed Dyslipidemia. |
|
|
Jun 30, 2021 |
365 |
| Lassa fever vaccine undergoing clinical trial in Nigeria - US. |
|
|
Jun 29, 2021 |
607 |
| Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. |
|
|
Jun 29, 2021 |
202 |
| Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. |
|
|
Jun 29, 2021 |
201 |
| Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. |
|
|
Jun 29, 2021 |
203 |
| VBI Vaccines Touts Initial Positive Phase 1 Data for Its eVLP Vaccine Candidate Against COVID-19. |
|
|
Jun 29, 2021 |
400 |
| SAB Biotherapeutics Doses First Participant in Phase 2a Trial of SAB-176 for the Treatment of Influenza. |
|
|
Jun 29, 2021 |
531 |
| Cerevel Therapeutics announces results from Phase 1b clinical trial of CVL-231. |
|
Financial report |
Jun 29, 2021 |
179 |
| Altimmune announces update on AdCOVID Phase 1 Clinical trial. |
|
|
Jun 29, 2021 |
181 |
| Altimmune to terminate further enrollment, evaluate future options for T-COVID. |
|
|
Jun 29, 2021 |
219 |
| Kymera Therapeutics reports 'positive' results from Phase 1 trial of KT-474. |
|
|
Jun 28, 2021 |
302 |
| AstraZeneca says first participants vaccinated in COVID-19 variant vaccine trial. |
|
|
Jun 28, 2021 |
195 |
| Anavex announces results of ANAVEX 2-73 in phase 2 clinical trial. |
|
Financial report |
Jun 28, 2021 |
459 |
| Galera Therapeutics completes enrollment of phase 3 trial of avasopasem. |
|
|
Jun 28, 2021 |
183 |
| WPD Pharmaceuticals plans to commence Phase 1b/II study of berubicin. |
|
|
Jun 28, 2021 |
608 |
| Crinetics announces dosing of first patient in phase 3 PATHFNDR-1 study. |
|
|
Jun 28, 2021 |
171 |
| Onconova provides update on Phase 1/2a trial of rigosertib-nivolumab combination. |
|
|
Jun 28, 2021 |
160 |
| Dare Bioscience announces Phase 1 results for DARE-HRT1. |
|
Financial report |
Jun 28, 2021 |
730 |
| Catalyst Biosciences receives FDA Fast Track Designation for subcutaneous MarzAA. |
|
|
Jun 28, 2021 |
206 |
| Oric Pharmaceuticals announces FDA clearance of IND application for ORIC-533. |
|
|
Jun 28, 2021 |
256 |
| Veru announce presentation of Phase 1b/2 clinical study update for sabizabulin. |
|
|
Jun 28, 2021 |
153 |
| Ampio Pharmaceuticals initiates patient randomization and dosing in AP-019 Phase II study of inhaled Ampion in COVID-19 respiratory distress. |
|
|
Jun 28, 2021 |
211 |
| Ampio Pharmaceuticals initiates patient randomization and dosing in AP-019 Phase II study of inhaled Ampion in COVID-19 respiratory distress. |
|
|
Jun 28, 2021 |
212 |
| AstraZeneca commences trial testing of COVID-19 vaccine against the Beta virus variant. |
|
|
Jun 28, 2021 |
187 |
| American Diabetes Association's clinical trial finds dapagliflozin was well tolerated in hospitalised COVID-19 patients. |
|
|
Jun 28, 2021 |
254 |
| AstraZeneca commences trial testing of COVID-19 vaccine against the Beta virus variant. |
|
|
Jun 28, 2021 |
186 |
| American Diabetes Association's clinical trial finds dapagliflozin was well tolerated in hospitalised COVID-19 patients. |
|
|
Jun 28, 2021 |
253 |
| Patient Randomization and Dosing Starts in Ampio Pharmaceuticals AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress. |
|
|
Jun 28, 2021 |
285 |
| Taiwan's UBI claims vaccine effective against Delta variant, booster trials soon in US. |
|
|
Jun 28, 2021 |
303 |
| First trials for cancer vaccine under way in the city. |
JONATHAN HUMPHRIES ECHO reporter jonathan.humphries@trinitymirror.com @JHUMPHRIESECHO |
|
Jun 28, 2021 |
488 |
| Intellia, Regeneron announce interim data from Phase 1 study of NTLA-2001. |
|
|
Jun 27, 2021 |
440 |
| Health ministry aims to complete third phase human trial of Vietnamese-made vaccine in August. |
|
|
Jun 26, 2021 |
471 |
| S. Korea to give all-out support for phase 3 trials of homegrown COVID-19 vaccine candidates. |
|
|
Jun 25, 2021 |
298 |
| Sirnaomics doses first patient with STP705 in Phase one United States clinical study for liver cancer. |
|
Clinical report |
Jun 25, 2021 |
158 |
| Sirnaomics doses first patient with STP705 in Phase one United States clinical study for liver cancer. |
|
Clinical report |
Jun 25, 2021 |
159 |
| Phase III Pivotal Trial of Once Weekly Exenatide in Adolescents aged 10-17 Shows Benefit for the Treatment of Type 2 Diabetes. |
|
|
Jun 25, 2021 |
262 |
| Evaluation of the distance between the central teeth after frenectomy: a randomized clinical study. |
Tanik, Abdulsamet; Cicek, Yasin |
Clinical report |
Jun 25, 2021 |
4255 |
| Veru enrolls first patient in phase 3 VERACITY clinical trial of sabizabulin. |
|
Clinical report |
Jun 25, 2021 |
263 |
| Vir Biotechnology presents clinical data from trials of VIR-2218, VIR-3434. |
|
|
Jun 25, 2021 |
732 |
| AstraZeneca reports exenatide Phase 3 trial in adolescents met primary endpoint. |
|
|
Jun 25, 2021 |
170 |
| Applied Genetic reports 12-month data from ongoing Phase 1/2 trial of ACHM B3. |
|
|
Jun 24, 2021 |
293 |
| Applied Genetic reports 12-month data from ongoing Phase 1/2 trial of ACHM A3. |
|
|
Jun 24, 2021 |
151 |
| Longeveron announces abstract on data of Phase 1 trial of Lomecel-B infusion. |
|
|
Jun 24, 2021 |
210 |
| Brickell Biotech announce initiation of Phase 1 study of sofpironium bromide gel. |
|
|
Jun 24, 2021 |
209 |
| BioVie announces first patient enrolled in BIV201 Phase 2b clinical trial. |
|
|
Jun 24, 2021 |
233 |
| Aeglea BioTherapeutics begins dosing in Phase 1/2 trial of AGLE-177. |
|
|
Jun 24, 2021 |
171 |
| Kura Oncology doses first patient in Phase 1b portion of KOMET-001 trial. |
|
|
Jun 24, 2021 |
191 |
| US FDA approves Resolve Therapeutics' phase two clinical trial of RSLV-132 in long COVID patients. |
|
|
Jun 24, 2021 |
212 |
| NIH commences clinical trial to evaluate immune response of COVID-19 vaccines in pregnant women. |
|
|
Jun 24, 2021 |
177 |
| US FDA approves Resolve Therapeutics' phase two clinical trial of RSLV-132 in long COVID patients. |
|
|
Jun 24, 2021 |
211 |
| Resolve Therapeutics announces FDA approval to commence phase 2 trial of RSLV-132 in long COVID patients. |
|
|
Jun 24, 2021 |
231 |
| Resolve Therapeutics announces FDA approval to commence phase 2 trial of RSLV-132 in long COVID patients. |
|
|
Jun 24, 2021 |
232 |
| First Patient Dosed in Synergy, ALPN-101 Phase 2 Lupus Clinical Trial and USD 45m in Development Milestones Achieved Under AbbVie Collaboration. |
|
|
Jun 24, 2021 |
333 |
| Shenzhen Kangtai Biological Products Co Ltd announces launch of Phase III clinical trial of BIOKANGTAI COVID-19 vaccine in Malaysia. |
|
|
Jun 23, 2021 |
191 |
| Innovent Biologics meets overall survival primary endpoint in phase 3 ORIENT-15 study. |
|
Clinical report |
Jun 23, 2021 |
193 |
| Shenzhen Kangtai Biological Products Co Ltd announces launch of Phase III clinical trial of BIOKANGTAI COVID-19 vaccine in Malaysia. |
|
|
Jun 23, 2021 |
190 |
| Innovent Biologics meets overall survival primary endpoint in phase 3 ORIENT-15 study. |
|
Clinical report |
Jun 23, 2021 |
192 |
| Seven and Eight Biopharmaceuticals Inc. Announces the First Patient Treated in a First-in-Human Clinical Trial of the TLR7/8 Dual Agonist BDB018 in Advanced Solid Tumors. |
|
|
Jun 23, 2021 |
271 |
| Poxel and Sumitomo Dainippon Pharma Announce the Approval of TWYMEEG for the Treatment of Type 2 Diabetes in Japan. |
|
|
Jun 23, 2021 |
461 |
| AstraZeneca's Orpathys granted conditional approval in China to treat NSCLC. |
|
|
Jun 23, 2021 |
154 |
| BioCardia says DSMB recommends continuation of Phase III CardiAMP study. |
|
|
Jun 23, 2021 |
196 |
| XBiotech announces first patient enrolled in clinical trial evaluating XB2001. |
|
Clinical report |
Jun 23, 2021 |
205 |
| Entera Bio announce phase 2 BMD data for EB613. |
|
Clinical report |
Jun 23, 2021 |
548 |
| Medicenna submits clinical trial application in Australia for study of MDNA11. |
|
Report |
Jun 23, 2021 |
317 |
| Alterity Therapeutics receives EU guidance for Phase 2 trial of MSA candidate. |
|
|
Jun 23, 2021 |
153 |
| E.U. grants AstraZeneca/Merck's Koselugo conditional approval for PN treatment. |
|
|
Jun 22, 2021 |
221 |
| Dicerna begins dosing on ESTRELLA trial of belcesiran for AATLD treatment. |
|
|
Jun 22, 2021 |
182 |
| BioCardia to present CardiAMP cell therapy trial data. |
|
|
Jun 22, 2021 |
232 |
| Jupiter Wellness publishes results of clinical study for eczema treatment. |
|
Clinical report |
Jun 22, 2021 |
276 |
| Antares Pharma announces submission of IND application for ATRS-1902. |
|
|
Jun 22, 2021 |
233 |
| Sorrento Therapeutics Phase 2 abivertinib studies have completed enrollment. |
|
Clinical report |
Jun 22, 2021 |
180 |
| ADC Therapeutics announces interim results from Phase 2 clinical trial of Cami. |
|
|
Jun 22, 2021 |
325 |
| Hope Biosciences Stem Cell Research Foundation wins FDA's approval for simultaneous stem cell trials for Parkinson's Disease. |
|
|
Jun 22, 2021 |
205 |
| Hope Biosciences Stem Cell Research Foundation wins FDA's approval for simultaneous stem cell trials for Parkinson's Disease. |
|
|
Jun 22, 2021 |
204 |
| Xentria Initiates Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis. |
|
|
Jun 22, 2021 |
383 |
| MediciNova announces publication of results from Phase 2 trial of MN-166. |
|
Clinical report |
Jun 21, 2021 |
281 |
| Sierra Oncology announces completion of enrollment for MOMENTUM phase 3 trial. |
|
|
Jun 21, 2021 |
185 |
| Anavex announces data from Phase 2 trial of ANAVEX 2-73. |
|
|
Jun 21, 2021 |
414 |
| Aligos Therapeutics to present Phase 1 data for ALG-010133. |
|
Drug overview |
Jun 21, 2021 |
876 |
| Immutep to evaluate efti in triple combination therapy Phase I study. |
|
|
Jun 21, 2021 |
201 |
| Syneos Health accelerates decentralized clinical trial delivery. |
|
|
Jun 21, 2021 |
230 |
| Moleculin Biotech enrolls, doses first patient in phase 1b/2 trial of annamycin. |
|
|
Jun 21, 2021 |
237 |
| Cassava Sciences to initiate Phase 3 program of simufilam in 2H21. |
|
|
Jun 21, 2021 |
199 |
| AIM ImmunoTech completes all treatments in Phase 1 study of ampligen. |
|
|
Jun 21, 2021 |
262 |
| Cassava selects Premier Research for Phase 3 of Alzheimer's program. |
|
|
Jun 21, 2021 |
162 |
| Vicky: I'm not looking for a miracle ...all I want is more time; CERVICALCHECK SURVIVOR VICKY Y PREPARES TO FLY HOME TO FAMILY Battler Vicky coping through trial cancer treatment EXCLUSIVE. |
SYLVIA POWNALL |
|
Jun 20, 2021 |
1270 |
| WHO to cover 3 vaccines in Philippines trials. |
|
|
Jun 20, 2021 |
426 |
| Vicky taken to hospital after clinical trial scare. |
MARITA MOLONEY |
|
Jun 19, 2021 |
216 |
| Appili Therapeutics Inc expands COVID-19 PRESECO Clinical Trial of Avigan/Reeqonus into Mexico and Brazil. |
|
|
Jun 18, 2021 |
237 |
| Jacobio Pharmaceuticals doses first patients in clinical trial of SHP2 inhibitor JAB-3312 in combination with Pembrolizumab and Binimetinib. |
|
|
Jun 18, 2021 |
162 |
| Bangladeshi COVID-19 vaccine gets conditional clearance for human trials. |
SHEHAB SUMON |
|
Jun 18, 2021 |
519 |
| Appili Therapeutics Inc expands COVID-19 PRESECO Clinical Trial of Avigan/Reeqonus into Mexico and Brazil. |
|
|
Jun 18, 2021 |
236 |
| Jacobio Pharmaceuticals doses first patients in clinical trial of SHP2 inhibitor JAB-3312 in combination with Pembrolizumab and Binimetinib. |
|
|
Jun 18, 2021 |
161 |
| Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan. |
|
Clinical report |
Jun 18, 2021 |
539 |
| Iveric bio to present GATHER2 enrollment data, GATHER1 analyses. |
|
|
Jun 18, 2021 |
236 |
| ADC Therapeutics presents data on four Zynlonta clinical trials. |
|
|
Jun 18, 2021 |
301 |
| Novartis reports data from completed two-copy cohort of Phase 3 SPR1NT trial. |
|
|
Jun 18, 2021 |
242 |
| Aerie Pharma completes enrollment in Phase 3 trial of ophtalmic solution. |
|
|
Jun 17, 2021 |
176 |
| Viking Therapeutics reports results from Phase 1 trial of VK0214. |
|
|
Jun 17, 2021 |
208 |
| Biogen announces first patient dosed in phase 3 clinical study of TOPAZ-1. |
|
Clinical report |
Jun 17, 2021 |
262 |
| Appili Therapeutics Expands PRESECO Clinical Trial of Avigan/Reeqonus for Mild-to-Moderate COVID-19 Patients into Mexico and Brazil. |
|
|
Jun 17, 2021 |
773 |
| Over-70s wanted for booster vaccine trial. |
|
|
Jun 17, 2021 |
222 |
| Geron says IMbark Phase 2 data published in Journal of Clinical Oncology. |
|
Clinical report |
Jun 17, 2021 |
231 |
| SpringsWorks Therapeutics initiates Phase 1/2 trial of mirdametinib in glioma. |
|
|
Jun 16, 2021 |
191 |
| RECOVERY trial finds Regeneron's COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies. |
|
|
Jun 16, 2021 |
246 |
| Organicell Touts Positive Results of Their Expanded Access Trial for the Treatment of Mild to Moderate COVID-19 Using Zofin. |
|
|
Jun 16, 2021 |
364 |
| China's nasal-spray Covid-19 vaccines undergoing clinical trials:. |
Xinhua News Agency |
|
Jun 16, 2021 |
315 |
| Ashvattha Therapeutics Touts Positive Interim Data from Ongoing Phase 2 PRANA Clinical Study of OP-101 in Severe COVID-19 Patients. |
|
Clinical report |
Jun 16, 2021 |
159 |
| RECOVERY trial finds Regeneron's COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies. |
|
|
Jun 16, 2021 |
247 |
| Freeline doses second patient in Phase 1/2 MARVEL-1 clinical trial. |
|
|
Jun 16, 2021 |
172 |
| Altimmune announces interim data from ALT-801 phase 1 trial. |
|
|
Jun 16, 2021 |
319 |
| uniQure enrolls first two patients in second cohort phase I/II trial of AMT-130. |
|
Clinical report |
Jun 16, 2021 |
195 |
| Aprea Therapeutics announces Phase 1/2 clinical trial results. |
|
|
Jun 16, 2021 |
259 |
| Argenx announces publication of Phase 3 ADAPT results in The Lancet Neurology. |
|
Financial report |
Jun 16, 2021 |
317 |
| Innovent Biologics doses first subject IBI362 phase two clinical trial. |
|
Clinical report |
Jun 15, 2021 |
295 |
| Ascentage Pharma's lisaftoclax Investigational New Drug application receives US FDA approval. |
|
|
Jun 15, 2021 |
167 |
| Innovent Biologics doses first subject IBI362 phase two clinical trial. |
|
Clinical report |
Jun 15, 2021 |
296 |
| Ascentage Pharma's lisaftoclax Investigational New Drug application receives US FDA approval. |
|
|
Jun 15, 2021 |
168 |
| Taiwanese COVID vaccine developer to conduct clinical trials in Paraguay. |
|
|
Jun 15, 2021 |
267 |
| Clearside report 'positive' safety results from OASIS Phase 1/2a trial of CLS-AX. |
|
|
Jun 15, 2021 |
255 |
| Otonomy initiates expansion of Phase 1/2 clinical trial for OTO-413. |
|
Clinical report |
Jun 15, 2021 |
168 |
| Salarius Pharmaceuticals announces new clinical trial to study seclidemstat. |
|
|
Jun 15, 2021 |
189 |
| Eyenovia provides update on three Phase 3 programs. |
|
|
Jun 15, 2021 |
322 |
| LivaNova gets FDA approval for study to evaluate aura6000 to treat Sleep Apnea. |
|
|
Jun 15, 2021 |
247 |
| First batch of Kangtai developed Covid-19 vaccine arrives in Malaysia for clinical trial. |
|
|
Jun 14, 2021 |
595 |
| Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in US NDA Phase 3 Clinical Trials for iDose TR. |
|
|
Jun 14, 2021 |
417 |
| Chula launches human trials of Thai Covid vaccine. |
|
|
Jun 14, 2021 |
263 |
| Novavax's COVID-19 vaccine found to be more than 90% effective in US clinical trial. |
|
|
Jun 14, 2021 |
293 |
| ImmVira announces completion of first dosing in phase II clinical trials of MVR-T3011 in US and China. |
|
|
Jun 14, 2021 |
197 |
| Novavax's COVID-19 vaccine found to be more than 90% effective in US clinical trial. |
|
|
Jun 14, 2021 |
294 |
| ImmVira announces completion of first dosing in phase II clinical trials of MVR-T3011 in US and China. |
|
|
Jun 14, 2021 |
198 |
| Novavax COVID-19 vaccine shows 90% efficacy, 100% protection in PREVENT-19 trial. |
|
|
Jun 14, 2021 |
466 |
| Landos Biopharma announce outcome of End-of-Phase 2 meeting with FDA. |
|
|
Jun 14, 2021 |
212 |
| Terns Pharmaceuticals reports results from phase 2a LIFT study of TERN-101. |
|
Clinical report |
Jun 14, 2021 |
299 |
| Rapt Therapeutics reports 'positive' results from Phase 1b RPT193 trial. |
|
Financial report |
Jun 14, 2021 |
257 |
| C4 Therapeutics first patient dosed in phase 1/2 clinical trial on CFT7455. |
|
|
Jun 14, 2021 |
238 |
| Fusion Pharmaceuticals reports results from Phase 1 study of FPI-1434. |
|
|
Jun 14, 2021 |
221 |
| Editas Medicine presents data supporting initiation of EDIT-301 Phase 1/2 RUBY. |
|
|
Jun 11, 2021 |
203 |
| Mustang Bio reports updated interim Phase 1/2 data for MB-106. |
|
|
Jun 11, 2021 |
268 |
| Novan reports 'positive' results from B-SIMPLE4 Phase 3 study of SB206. |
|
|
Jun 11, 2021 |
173 |
| Adamis Pharmaceuticals provides update on clinical trial progress for Tempol. |
|
Clinical report |
Jun 11, 2021 |
204 |
| X4 reports efficacy, safety data from Phase 1b mavorixafor study. |
|
|
Jun 11, 2021 |
240 |
| Pharmaxis progresses clinical trial in bone marrow cancer. |
|
|
Jun 11, 2021 |
381 |
| Orgenesis says enrollment is underway for a Phase 2 rotator cuff repair study of its Tissue Genesis Icellator. |
|
|
Jun 11, 2021 |
362 |
| Pharmaxis progresses clinical trial in bone marrow cancer. |
|
|
Jun 11, 2021 |
381 |
| First volunteer at Sussex hospital receives covid booster jab in world-leading trial; A hospital worker has become the first person at a Sussex trust to receive a covid booster jab as part of a world-first clinical trial. |
Isabella Cipirska |
|
Jun 11, 2021 |
542 |
| Finish clinical trials first before vaccinating minors DOST. |
|
|
Jun 11, 2021 |
249 |
| Phase II results of Taiwan's COVID-19 vaccine meet safety, efficacy thresholds. |
|
|
Jun 10, 2021 |
328 |
| When does Bangavax get cleared for clinical trials? |
|
|
Jun 10, 2021 |
646 |
| IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients. |
|
|
Jun 10, 2021 |
498 |
| First Clinical Trial Application Authorization Received in the EU for its Phase 2 Study of NT-I7 and Opdivo. |
|
|
Jun 10, 2021 |
338 |
| Texas Children's Hospital, Baylor College & Biological E. Limited enter Phase III Trials in India for "People's COVId-19 Vaccine" for the underserved nations. |
|
|
Jun 10, 2021 |
287 |
| Texas Children's Hospital, Baylor College & Biological E. Limited enter Phase III Trials in India for "People's COVId-19 Vaccine" for the underserved nations. |
|
|
Jun 10, 2021 |
288 |
| MigVax's Subunit Oral COVID-19 Vaccine Preclinical Trial Demonstrates Effectivity as a Booster. |
|
|
Jun 10, 2021 |
151 |
